4-butyrolactone has been researched along with potassium chloride in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harsing, LG; Vizi, ES | 1 |
| Hong, JS; Hudson, PM; Nanry, KP; Stachowiak, MK; Tilson, HA; Zhang, WQ | 1 |
| Banerjee, PK; Hu, RQ; Snead, OC | 1 |
| Cao, YX; He, JY; He, LC; Xu, CB; Zhang, W | 1 |
| Chen, H; Gao, W; Huo, L; Li, Y; Qu, Z; Zhang, J | 1 |
5 other study(ies) available for 4-butyrolactone and potassium chloride
| Article | Year |
|---|---|
Alpha 2-adrenoceptors are not involved in the regulation of striatal glutamate release: comparison to dopaminergic inhibition.
Topics: 4-Butyrolactone; Animals; Apomorphine; Berberine; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Drug Interactions; Glutamates; Glutamic Acid; Haloperidol; Hydrazines; Hydroxydopamines; Male; Oxidopamine; Potassium Chloride; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Secretory Rate; Synaptic Transmission; Yohimbine | 1991 |
Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.
Topics: 4-Butyrolactone; Animals; Corpus Striatum; Dopamine; Furans; Haloperidol; Homovanillic Acid; Hydroxydopamines; Male; Oxidopamine; Potassium Chloride; Rats; Rats, Inbred F344; Substantia Nigra | 1988 |
Regulation of gamma-aminobutyric acid (GABA) release in cerebral cortex in the gamma-hydroxybutyric acid (GHB) model of absence seizures in rat.
Topics: 4-Butyrolactone; Animals; Cerebral Cortex; Electroencephalography; Epilepsy, Absence; GABA Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Hydroxybutyrates; Male; Microdialysis; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptors, GABA-B; Solvents; Thalamus | 2000 |
Ligustilide induces vasodilatation via inhibiting voltage dependent calcium channel and receptor-mediated Ca2+ influx and release.
Topics: 4-Butyrolactone; Animals; Caffeine; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Chloride; Calcium Signaling; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Mesenteric Artery, Superior; Myography; Norepinephrine; Potassium Chloride; Rats; Ryanodine Receptor Calcium Release Channel; Serotonin; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2006 |
Vasorelaxant effects of Shunaoxin pill are mediated by NO/cGMP pathway, HO/CO pathway and calcium channel blockade in isolated rat thoracic aorta.
Topics: 4-Butyrolactone; Animals; Aorta, Thoracic; Calcium; Calcium Channel Blockers; Calcium Channels; Carbon Monoxide; Coumaric Acids; Cyclic GMP; Drugs, Chinese Herbal; Heme Oxygenase (Decyclizing); In Vitro Techniques; Male; Nitric Oxide; Norepinephrine; Potassium Chloride; Rats, Wistar; Tablets; Vasodilator Agents | 2015 |